AstraZeneca AB v. Sun Pharma Global FZE et al > Summary
Court Case Number 1:14-cv-00694
Filing Date Jun 2, 2014
Court Delaware District Court
Status Unknown
Plaintiff
Plaintiff Attorneys
4AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
Defendant Attorneys
12Sun Pharmaceutical Industries Ltd.
Attorney Name: David A. Bilson
Phillips, McLaughlin & Hall, P.A.
Sun Pharma Global FZE
Attorney Name: Megan C. Haney
Phillips, McLaughlin & Hall, P.A.
Sun Pharmaceutical Industries Ltd.
Attorney Name: Megan C. Haney
Phillips, McLaughlin & Hall, P.A.
Sun Pharma Global FZE
Attorney Name: John K. Hsu
ArentFox Schiff
Sun Pharma Global FZE
Attorney Name: James F. Hurst
Kirkland & Ellis
Sun Pharma Global FZE
Attorney Name: Charles B. Klein
Winston & Strawn
Sun Pharma Global FZE
Attorney Name: Samuel S. Park
Winston & Strawn
Sun Pharma Global FZE
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Sun Pharmaceutical Industries Ltd.
Attorney Name: John C. Phillips, Jr.
Phillips, McLaughlin & Hall, P.A.
Sun Pharma Global FZE
Attorney Name: Maureen L. Rurka
Winston & Strawn
Sun Pharma Global FZE
Attorney Name: Christopher P. Wilson
Winston & Strawn
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08628799 | Coated tablet formulation and method | Jan 14, 2014 |
| RE044186 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method | Apr 30, 2013 |
| 07951400 | Coated tablet formulation and method | May 31, 2011 |
